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An fMRI study of facial emotion processing in
children and adolescents with 22q11.2 deletion
syndrome
Rayna Azuma1,2*†, Quinton Deeley2,3†, Linda E Campbell4, Eileen M Daly2, Vincent Giampietro5,
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Abstract
Background: 22q11.2 deletion syndrome (22q11DS, velo-cardio-facial syndrome [VCFS]) is a genetic disorder associated
with interstitial deletions of chromosome 22q11.2. In addition to high rates of neuropsychiatric disorders, children with
22q11DS have impairments of face processing, as well as IQ-independent deficits in visuoperceptual function and social
and abstract reasoning. These face-processing deficits may contribute to the social impairments of 22q11DS. However,
their neurobiological basis is poorly understood.
Methods: We used event-related functional magnetic resonance imaging (fMRI) to examine neural responses when
children with 22q11DS (aged 9–17 years) and healthy controls (aged 8–17 years) incidentally processed neutral
expressions and mild (50%) and intense (100%) expressions of fear and disgust. We included 28 right-handed children
and adolescents: 14 with 22q11DS and 14 healthy (including nine siblings) controls.
Results: Within groups, contrasts showed that individuals significantly activated ‘face responsive’ areas when viewing
neutral faces, including fusiform-extrastriate cortices. Further, within both groups, there was a significant positive linear
trend in activation of fusiform-extrastriate cortices and cerebellum to increasing intensities of fear. There were, however,
also between-group differences. Children with 22q11DS generally showed reduced activity as compared to controls in
brain regions involved in social cognition and emotion processing across emotion types and intensities, including
fusiform-extrastriate cortices, anterior cingulate cortex (Brodmann area (BA) 24/32), and superomedial prefrontal cortices
(BA 6). Also, an exploratory correlation analysis showed that within 22q11DS children reduced activation was associated
with behavioural impairment—social difficulties (measured using the Total Difficulties Score from the Strengths and
Difficulties Questionnaire [SDQ]) were significantly negatively correlated with brain activity during fear and disgust
processing (respectively) in the left precentral gyrus (BA 4) and in the left fusiform gyrus (FG, BA 19), right lingual gyrus
(BA 18), and bilateral cerebellum.
Conclusions: Regions involved in face processing, including fusiform-extrastriate cortices, anterior cingulate gyri, and
superomedial prefrontal cortices (BA 6), are activated by facial expressions of fearful, disgusted, and neutral expressions in
children with 22q11DS but generally to a lesser degree than in controls. Hypoactivation in these regions may partly
explain the social impairments of children with 22q11DS.
Keywords: Velo-cardio-facial syndrome (VCFS), 22q11.2 deletion syndrome (22q11DS), Emotion, fMRI, Children, Social
cognition
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Background
22q11.2 deletion syndrome (22q11DS), also known as
velo-cardio-facial syndrome (VCFS), is a genetic disorder
associated with a microdeletion in chromosome 22q11.2
[1-3]. It is the most common microdeletion syndrome
with an estimated prevalence of 1 in every 4,000 live
births [4-6]. While the physical phenotype is variable,
commonly reported features include characteristic facial
dysmorphology, congenital heart disease, and cleft palate
[7,8]. A characteristic behavioural phenotype in 22q11DS
has also been described—with high rates of schizophrenia,
attention deficit (hyperactivity) disorder (ADD, ADHD)
[3,8-13], autistic spectrum disorders, anxiety disorders,
and emotional instability [12-17]. In addition, children
and adults with 22q11DS typically have mild intellectual
disabilities and a characteristic cognitive profile—with par-
ticular deficits in visual-perceptual function and social and
abstract reasoning [3,17-26]. It has been suggested by
some that these cognitive deficits may contribute to the
social impairments frequently observed in 22q11DS [17].
It is well established that children with 22q11DS have
problems with social interaction, and perhaps, especially
with peer relations rather than with adult figures
[27-29]. For instance, it has been reported that people
with 22q11DS typically show a ‘bland affect’ with min-
imal facial expression, in addition to disinhibited and
impulsive or serious and shy extremes of behaviour
[17,25,30,31]. Furthermore, it has been reported that
20%–50% of children and adolescents in their sample of
22q11DS exhibited some ‘autism spectrum problem
[13,16,25,32-35].’ While reported prevalence of autistic
spectrum disorder (ASD) among 22q11DS varies widely
from study to study, it is nevertheless considerably
higher than in the general population which is around
1% to 1.5% [36-43]. Hence, impairment in social func-
tion may be a central feature of 22q11DS [44]. A recent
study has reported that weaker functional connectivity
between the posterior cingulate gyrus and other default
mode network nodes (such as the precuneus, precentral
gyrus, and left frontal pole) observed in individuals with
22q11DS was correlated with lower social competence
[44]. However, cognitive and/or functional neural sub-
strates underlying social impairment are undetermined.
The ability to perceive and respond to facial expres-
sions is crucial to managing social interactions and rela-
tionships, and deficits in face processing have often been
reported in clinical populations with social interaction
problems [45,46]. For instance, abnormalities in the ex-
pression and recognition of emotions have been re-
ported in people with ASD [47-49]. In 22q11DS, deficits
in memory for faces have been reported [18,50], and re-
cent behavioural studies have shown that children and
adolescents with 22q11DS have difficulties identifying
faces and facial emotions [18,51-56]. For instance, during
face identification and emotion recognition tasks, chil-
dren and adolescents with 22q11DS (as compared to con-
trols) make more errors and pay preferential attention to
the mouth rather than the eyes [51,52]. These deficits in
the recognition of faces and facial emotion may reflect
inefficient strategies employed by the individuals with
22q11DS and/or biological differences during facial emo-
tion processing.
In healthy humans, face processing engages a variety
of brain regions, some of which are common to all emo-
tion types (e.g. core visual analysis areas of striate and
extrastriate cortex, particularly the fusiform gyrus [FG])
[57,58]. Core visual analysis areas project to ‘down-
stream’ components of face responsive systems, in which
cortical and subcortical regions are differentially acti-
vated depending on stimulus features (e.g. neutral or
fearful face) and cognitive task (e.g. emotion recognition)
[59,60]. Further, identification of the emotional valence
of faces (and other stimuli) and the generation of emo-
tional responses typically require activity in a predomin-
antly ventral neural system. This includes the amygdala,
insula, ventral striatum, and ventral regions of the anter-
ior cingulate cortex and prefrontal cortex [46,57]. Fur-
thermore, within healthy populations, across different
emotions, as emotion intensity of a facial expression in-
creases, there is differential engagement of components
of face responsive networks such as core visual analysis
areas (including the FG) and limbic regions [60]. For ex-
ample, the amygdala and visual cortices are co-activated
in response to fearful faces. It has been proposed that
visual cortex activation is boosted by ‘feedback’ influ-
ences from the amygdala [61,62] and that this may con-
tribute to the detection and memorization of important
social cues [63]. Another structure that is implicated in
the processing of emotion is the cerebellum [64-67].
Studies have implicated the cerebellum in various as-
pects of emotional processing such as identification of
emotion in a speaker’s voice [68], induction of positive
and negative emotion [69,70], processing of positive and
negative emotional stimuli [71], and fear conditioning
[72,73]. It has been suggested that cerebellar activation
may be associated with processing of ‘primitive’ emotion
[74], but the exact nature of the contribution of the
cerebellum to emotion processing is still unclear.
To date, two imaging studies have investigated facial
emotion processing in 22q11DS. In the first functional
magnetic resonance imaging (fMRI) study [75], eight adults
with 22q11DS and nine age- and IQ-matched controls
were scanned during an incidental (gender discrimination)
task. Two types of facial emotions (happy or angry) and
neutral faces were presented in a block design. Individuals
with 22q11DS showed significant hypoactivation of the
right insula and of the frontal regions and higher activation
of the occipital regions compared to the controls. It was
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suggested that these findings may be partially explained by
dysmaturation of white matter tracts in 22q11DS [76,77]
and may underlie social-emotional dysfunction seen in this
population. However, this study employed a block design
that mixed both ‘happy’ and ‘angry’ faces—making it im-
possible to distinguish neural responses to two very differ-
ent emotions (i.e. one positive and one negative) or neutral
faces.
A more recent event-related fMRI study examined
brain activity in response to fearful and neutral facial ex-
pressions in young people with 22q11DS and controls
during an incidental (faces/houses categorization) task
[78]. The authors reported a lack of face-selective activa-
tion in FG and a lack of modulation of the amygdala and
superior temporal sulcus by fearful expressions. These
findings were associated with the absence of repetition-
suppression effect in 22q11DS, both of which were present
in the controls. The authors suggested that these functional
abnormalities in the FG, amygdala, and other face-related
areas may underlie social deficits in 22q11DS [78]. How-
ever, this study only employed one emotion type (fear) at a
single intensity (prototypic), whereas normal social inter-
action involves different types of facial expressions at dif-
ferent intensities [60]. Further, one third of the 22q11DS
group had psychotic symptoms, which may have contrib-
uted to the group differences observed in their study. For
example, several studies have reported abnormal brain ac-
tivity during facial emotion processing in people with
psychotic illness [79-81]; similarly, a recent study of facial
emotion processing in 22q11DS reported differences in
brain activations between 22q11DS volunteers with psych-
otic symptoms and those without [78].
In summary, previous studies point to abnormalities in
the neural responses associated with processing facial
expressions in 22q11DS [75,78]. However, it is unclear
whether (and how) the functional anatomy of these
neural responses may differ according to different types
of primary emotions and across a range of intensities. In
order to address these issues, studies are required in
young people without psychotic symptoms and across
more than one emotion type and intensity.
We therefore employed a cross-sectional event-related
design to investigate neural responses to neutral faces and
to two facial emotions (fear, disgust) with high (100%) and
mild (50%) emotional intensities in children and adoles-
cents with 22q11DS. We selected fear and disgust out of
the basic human emotional expressions because of their
significance in the development of socialization skills. For
instance, it has been suggested that individuals learn to
avoid behaviours that are associated with fearful expres-
sions as they elicit an aversive arousal response [82]. We
also included disgust as it signals socially unacceptable be-
haviours as well as aversive stimuli (e.g. odours and/or
tastes associated with rotten food) [83]. Based on previous
studies, we predicted that typically developing children
would show differential activation of the limbic area de-
pending on emotion type (e.g. greater amygdala activation
for fear and insula activation for disgust) [45,46]. Given
the evidence of reduced recognition of facial expressions
of emotion in children with 22q11DS, we tested the main
hypothesis that they would show increased limbic and vis-
ual cortical responses as emotion intensity is increased
but that these responses would be significantly less than
those of healthy controls for both emotion types and in-
tensities. We also conducted exploratory correlation ana-
lysis, within the 22q11DS group, of measures of social
behaviour, as measured by the Strengths and Difficulties
Questionnaire (SDQ) [84-86] and neural activity in order
to determine what, if any, functional abnormalities may be
associated with social difficulties in people with 22q11DS.
Methods
Participants
We studied 28 children and adolescents; 14 with 22q11DS
and 14 normally developing controls. The 22q11DS group
comprised seven males and seven females, aged 9–17
years (mean age ± standard deviation, 13 ± 2 years), and
the healthy controls included nine males and five females,
aged 8–17 years (13 ± 3 years) (see Table 1 for demo-
graphic data). Where possible, we used sibling controls in
order to match for socio-cultural background. Nine of the
control group were siblings, and five were recruited from
the local community. All were right-handed.
All participants underwent psychiatric and physical
examination and routine blood tests. We excluded par-
ticipants with a clinically detectable co-morbid psychiatric
disorder or physical disorder affecting brain function (e.g.
ADHD, hypothyroidism, or epilepsy) or with a clinically
abnormal MRI scan—as determined by a neuroradiologist.
None of the participants had any psychotic symptoms,
and all were drug free at the time of testing.
The 22q11DS volunteers were recruited through the
22q11 (UK) Support group and the Behavioural Genetics
Clinic at the Maudsley Hospital/Institute of Psychiatry,
King’s College London. 22q11DS was diagnosed by
fluorescence in situ hybridization (FISH) using the N25
probe (Oncor Inc.). As exclusion criteria, we recruited
only those who had been able to successfully complete
MRI scanning for another study [87] and who had a
minimum Full Scale IQ (FSIQ) of 55, as the FSIQ of
children with 22q11DS tends to range from normal to
moderately learning disabled with a mean FSIQ of about
70 [17,21]. The ‘Autism Screening Questionnaire’ (ASQ)
was administered in order to measure autistic traits with
a cut-off score of 14 for those who may have autism and
who should have a more complete assessment [88]. The
ASQ score was significantly higher in the 22q11DS
group than in the controls (t(18) = 2.12, p < .05), but
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none scored above the cut-off. We measured ADHD
symptoms with the ‘Conners Rating Scales’ (CRS)
[89,90]. Among those who agreed to provide the data,
children with 22q11DS scored significantly higher (60 ±
10) than the controls (48 ± 5). Further, in view of the
high rates of schizotypy reported in 22q11DS adults [9],
an assessment of schizotypal traits was also performed.
However, since there was no validated measure for
schizotypy in learning-disabled children, we constructed
a preliminary comparative schizotypy scale derived from
DSM-IV [91]. Of those who agreed to provide the infor-
mation, 6 out of 11 children with 22q11DS scored at
least one positive rating (score range 0–7, mean ± SD:
2 ± 2), whereas none of the 9 controls did. This may in-
dicate a higher level of schizotypy traits in the VCFS
sample, although the schizotypy scale itself needs to be
validated. The Wechsler Intelligence Scale for Children-
III (WISC-III) [92] was used to assess general intellec-
tual function. The mean FSIQ and standard deviation
for individuals with 22q11DS and controls were 66 ± 7
and 114 ± 16, respectively. All the participants and/or
their parents gave written informed consent/assent as
approved by the local research ethics committee (Insti-
tute of Psychiatry, South London and Maudsley Trust,
067/00).
The parent’s version of the SDQ [84-86,93] was used
to measure emotional symptoms, conduct problems,
hyperactivity, peer problems, and prosocial behaviour.
The Total Difficulties Score is generated by summing
the scores from all the scales except the Prosocial scale
(where normal-abnormal direction of the scores is the
opposite from the others). The SDQ is a well-validated
behavioural screening questionnaire and the Total Diffi-
culties Score provides an aggregate measure of difficul-
ties in the behaviours, emotions, and relationships of
children and young people.
Functional neuroimaging task
Each volunteer participated in two 6-min event-related
fMRI experiments. In each experiment, participants were
presented with facial expressions of one of two primary
emotions (disgust, fear) and neutral expressions from a
standardized series of prototypical facial expressions
posed by ten different volunteers [60,94]. The ten proto-
typical expressions of primary emotions were further
manipulated by morphing software to depict expressions
of mild (50%) and high (100%) intensity along the
neutral-prototypical expression continuum [94]. Thus,
there were ten faces with three levels of intensity, each
of which was presented twice to give a total of 60 stimuli
per experiment.
For example, in the ‘disgust’ experiment, participants
viewed prototypically disgusted (i.e. expressions of 100%
disgust), mildly disgusted (i.e. expressions of 50% dis-
gust), and neutral expressions. Each facial stimulus was
presented for 2 s. All stimuli were presented in a pseu-
dorandomized order to avoid successive presentation of
expressions of the same emotional intensity. Each stimu-
lus type was preceded by similar numbers of each of
the other two stimulus types to minimize the effect of
the preceding stimulus type on neural responses to the
stimulus of interest. The duration of the interstimulus
interval (ISI) varied from 3 to 8 s (average 4.9 s) accord-
ing to a Poisson distribution to prevent participants pre-
dicting the timing of the next stimulus presentation.
During the ISI, participants viewed a fixation cross (see
Figure one, Surguladze et al., for the design [60]). In sub-
sequent analyses, the fixation cross was used as the base-
line stimulus in each of the experiments. Participants
were requested to decide on the sex of each face and
press one of two buttons accordingly with the right
thumb. The participants were familiarized with the stim-
uli and task procedures before scanning. In prescan test-
ing where participants were shown the same faces as the
Table 1 Demographic data and task performance
22q11DS Control p value
n = 14 n = 14 (9)
Age range (mean ± SD) 9–17 (13 ± 2) 8–17 (13 ± 3) 0.942
Sex: M/F 7/7 9(5)/5(4)
FSIQ (WISC-III) 66 ± 7 114 ± 16 0.000**
PIQ (WISC-III) 67 ± 8 108 ± 19 0.000**
VIQ (WISC-III) 70 ± 12 111 ± 16 0.000**
ASQ n = 12 n = 8
6 ± 4 2 ± 3 0.048*
ADHD index n = 11 n = 9
60 ± 10 48 ± 5 0.039*
SDQ n = 11 n = 9
Total difficulties 13.9 ± 7.1 6.2 ± 4.1 0.011*
Emotional symptoms 3.6 ± 3.3 0.7 ± 0.7 0.117*
Conduct problems 2.1 ± 1.6 1.6 ± 1.6 0.471
Hyperactivity 5.2 ± 3.3 3.2 ± 2.9 0.182
Peer problems 3 ± 2.7 0.8 ± 1.4 0.040*
Prosocial behavioura 7.9 ± 1.6 8.6 ± 1.4 0.354
Gender discrimination task
Fear accuracy 73 ± 20 83 ± 17 0.15
Fear response time 771 ± 212 842 ± 109 0.279
Disgust accuracy 81 ± 9 83 ± 17 0.606
Disgust response time 883 ± 139 840 ± 126 0.408
Accuracy and response time for the gender discrimination task for 22q11DS
group and the controls. ADHD index which is a subscale of the ‘Conners
Rating Scales’ (CRS).
FSIQ full scale IQ, PIQ performance IQ, VIQ verbal IQ, ASQ Autism Screening
Questionnaire, SDQ Strengths and Difficulties Questionnaire.
*Significant at a trend level p < 0.05; **significant at p < 0.001; areverse scale.
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test version but with neutral expressions only, they were
all able to identify the sex of the faces correctly.
Image acquisition
Magnetic resonance (MR) images were acquired using a
GE Signa 1.5 Tesla system (General Electric, Milwaukee,
WI) with an operating console and software (Advanced
Nuclear Magnetic Resonance, Woburn, MA) for gra-
dient echo echoplanar imaging (EPI) at the Maudsley
Hospital, London, UK. A quadrature birdcage headcoil
was used for RF transmission and reception. An inver-
sion recovery EPI dataset was acquired at 43 near-axial
3-mm-thick planes parallel to the AC-PC line: TE
73 ms, TI 180 ms, TR 16 s, in-plane voxel size 1.72 ×
1.72 mm, interslice gap 0.3 mm, and matrix size: 128 ×
128 pixels. This higher-resolution EPI dataset provided
whole brain coverage and was later used to register the
fMRI datasets acquired from each individual in standard
stereotactic space. T2*-weighted images (180) depicting
blood oxygenation level-dependent (BOLD) contrast
were acquired at each of 16 near-axial non-contiguous
7-mm-thick planes parallel to the intercommissural
(AC-PC) line: TE 40 ms, TR 2 s, in-plane voxel size
3.44 × 3.44 mm, interslice gap 0.7 mm, and matrix size:
64 × 64 pixels.
Visual stimuli were presented via a conventional PC
and LCD projector system to a screen placed at the feet
of the participant and projected to them via a well-
positioned mirror, and overt responses were made using
an MR-compatible 2-button box placed in the partici-
pant’s dominant right hand. Presentation of all stimuli
and recording of all participant responses were synchro-
nized to the imaging system. The total functional image
acquisition time for each experiment was 6 min.
Neuroimaging data analysis
Individual brain activation maps
Data were analysed using a non-parametric approach
with XBAM (version 4) brain image analysis software
developed at the Institute of Psychiatry [95]. The images
were first processed to minimize motion-related arte-
facts [96]. A 3D volume consisting of the average in-
tensity at each voxel over the whole experiment was
calculated and used as a template. The 3D image volume
at each time point was then realigned to this template. Fol-
lowing realignment, data were detrended and smoothed
using a Gaussian filter (FWHM 7.2 mm) to improve the
signal-to-noise characteristics of the images. We did not
exclude any subjects based on motion because mean mo-
tion in each of the X-Y-Z direction was under 1 mm for all
of these subjects that were tested. This low level of motion
artefact may be because we recruited 22q11DS and sibling
participants from a sample that had successfully completed
MRI structural scanning prior to this study.
Experimental responses were analysed by convolving
each contrast of interest (neural responses to neutral
versus baseline, emotional expressions versus baseline,
respectively, and emotional expressions versus neutral)
with two gamma variate functions (peak responses at 4
and 8 s, respectively). These two functions were chosen
to encompass the known range of times to peak re-
sponse following stimulus onset for BOLD effects. The
best fit between the weighted sum of these convolutions
and the time series at each voxel was computed using
Friman’s constrained BOLD effect model [97]. Following
the computation of the model fit, a goodness-of-fit stat-
istic was computed. This consisted of the ratio of the
sum of squares of deviations from the mean image in-
tensity (over the whole time series) due to the model to
the sum of squares of deviations due to the residual sum
of squares (SSQ) ratio. Following the computation of the
observed SSQ ratio at each voxel, the data were per-
muted by the wavelet-based method described in [98].
This allowed the data-driven calculation of the null distri-
bution of SSQ ratios under the assumption of a no experi-
mentally determined response. Using this distribution, it is
possible to calculate the critical value of the SSQ ratio
needed to threshold the maps at any desired type I error
rate. The detection of activated voxels was then extended
from the voxel-to-cluster level using the method described
in detail by [99].
Group brain activation maps
The observed and permuted SSQ ratio maps for each in-
dividual were transformed into standard space [100]
using a two-stage warping procedure described in detail
in [95]. Group activation maps were then computed by
determining the median SSQ ratio at each voxel (over all
individuals) in the observed and permuted data maps
(medians are used to minimize outlier effects). In the
two-level clustering procedure (described in detail in
Bullmore et al, 1999 [99]), the first (voxel-wise) thresh-
olding was carried out at an uncorrected p value of 0.05
to give the maximum allowable sensitivity. In order to
eliminate the resulting false positive activations, a sec-
ond cluster-level thresholding step was carried out and
the threshold of this second step was adjusted to give an
expectation of less than one false positive cluster over
the whole brain. Thus, the computation of a standard-
ized measure of SSQ ratio at the individual level,
followed by analysis of the median SSQ ratio maps over
all individuals, treats intra- and interparticipant varia-
tions in effect separately. This constitutes a mixed-effect
approach that allows for inferences from these results to
be made about the larger population—in other words,
people with 22q11DS as a whole (assuming a representa-
tive sample).
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Within-group linear trend analysis
Voxel- and cluster-wise within-group differences in BOLD
signal change to the two different types of facial expres-
sion versus the baseline were examined using repeated
measures analysis of variance (ANOVA), with intensity
(neutral, 50% intensity, 100% intensity) as the within-
participant variable. Each ANOVA was constrained to
detect brain regions demonstrating linear trends of activa-
tion—in other words, areas where activity changes in a
stepwise way across levels of emotion intensity regardless
of direction (i.e. both positive and negative trends).
Between-group and group-by-intensity interaction analysis
A 3 × 2 repeated measures ANOVA was undertaken to
determine voxel- and cluster-wise between-group differ-
ences in BOLD signal to the two different types of facial
expression versus baseline, with intensity (neutral, 50%
intensity, 100% intensity) as the within-participant vari-
able for each emotion type and group (22q11DS, con-
trols) as the between-group variable. Group × intensity
interactions refer to brain regions showing differences in
the effect of changes in emotion intensity on neural re-
sponse in children with 22q11DS relative to healthy con-
trols. The main effects of group refer to the differences
between children with 22q11DS relative to controls in
the neural response to all emotion intensities (neutral,
mild, and intense) considered together.
Post hoc analysis
Further tests of between-group differences in neural
response to each of the three different emotion
expression-baseline contrasts for each separate emotion
were examined with post hoc ANOVAs. In addition,
neural responses to neutral expressions from both exper-
iments were combined to increase experimental power.
Correlations between brain activity during facial emotion
processing and social behaviour
We also conducted an exploratory correlation analysis,
within the 22q11DS group, of measures of social behav-
iour and brain activity in regions where healthy controls
activated significantly more than the 22q11DS group (i.e.
employing a ‘mask’ derived from brain regions showing
a main effect of group on neural responses to facial ex-
pressions for fearful and disgusted expressions respect-
ively.) Since not all the guardians agreed to complete
these questionnaires, we could only include data from
11 of the 14 children with 22q11DS for this analysis.
The aim was to determine what, if any, functional abnor-
malities might be associated with social difficulties in
people with 22q11DS as measured by SDQ total difficul-
ties score (abnormal score ≥17).
Results
Demographic details and behavioural results
There were no significant between-group differences in
age (t(26) = .07, p > .05), response accuracy (Fear: t(26) =
1.48, p > .05; Disgust: t(26) = .52, p > .05), or reaction
times (Fear: t(26) = 1.12, p > .05; Disgust: t(26) = .84,
p > .05). However, as noted above, as expected, the
healthy controls had a significantly higher FSIQ (t(26) =
10.4, p < .001) (see Table 1).
Face versus fixation cross contrasts
Results of contrasts of neutral faces versus fixation cross,
and prototypic (100% intensity) facial emotions versus
fixation cross for each group, are in the Additional file 1.
In summary, these contrasts revealed fusiform and
extrastriate activations in both children with 22q11DS
and controls, along with activation in other brain regions
involved in face perception (e.g. superior temporal gyri,
insula, anterior cingulate gyri, and medial frontal gyri).
Within group linear trend analysis
Table 2 shows results of repeated measures ANOVA of
neural responses to facial expressions of neutral, mild,
and intense emotion for fearful and disgusted expres-
sions, respectively. Positive linear trends (i.e. increased
levels of activation as the intensity of the facial expres-
sion increased) were found for fearful expressions in
both groups and for disgusted expressions in the
22q11DS group (Table 2). Negative linear trends of acti-
vation (i.e. decreased levels of activation as the intensity
of the facial expression increased) to disgusted expres-
sions were present in the controls (Table 2). In sum-
mary, we found significant positive trends of activation
in fusiform-extrastriate regions and cerebellum to in-
creasing intensities of fear in both groups, and positive
trends in similar areas to increasing intensities of facial
disgust in children and adolescents with 22q11DS.
Between-group and group-by-intensity interaction
analysis
The main effects of group on neural response to expres-
sion (neutral, mild, and intense emotion) and interac-
tions between group (controls, 22q11DS) and expression
intensity (neutral, mild, and intense emotion) for fearful
and disgusted expressions, respectively, are shown in
Table 3. Figures 1 and 2 show brain activation maps of
the main effects of group. Briefly, we found that, com-
pared to healthy controls, children with 22q11DS
showed reduced activations of the extrastriate cortices
(including FG), postcentral gyrus, precentral gyrus, and
cerebellum in response to the expressions of fear and
disgust (i.e. main effects of group). Tests of interactions
showed that there were significant group × intensity in-
teractions in the left precentral gyrus for fear, whereas
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the significant interactions for disgust were found in the
left precentral gyrus, the right cingulate gyrus, and the
left cerebellum. This result indicates that neural ‘hypore-
sponsiveness’ in children and adolescents with 22q11DS
varies depending on emotion type. Furthermore, the pat-
tern of the results remained unchanged even when we
repeated the analyses using FSIQ as a covariate to see if
any differences observed might reflect the differences in
FSIQ between the groups.
Post hoc analysis
To further clarify these group × intensity interactions
and the main effects of group, separate post hoc two-way
ANOVA comparisons of neutral, mild, and intense
Table 2 The effect of emotional intensity
22q11DS Controls
Brain region BA X Y Z Size p value X Y Z Size p value
FEAR
Middle occipital gyrus
Right 18 29 −78 −7 8
Lingual gyrus
Right 18 18 −78 −7 5
Precentral gyrus
Left 4 −36 −22 48 76 0.007657
Postcentral gyrus
Left 2 −47 −19 31 10
Inferior parietal lobule
Left 40 −40 −30 42 16
Cerebellum
Left −40 −63 −29 83 0.006032
Right 29 −78 −13 62 0.00486 32 −63 −29 83 0.007889
DISGUST
Inf-post temporal lobe
Right 37 36 −56 −2 96 0.008705
Middle occipital gyrus
Right 18 32 −78 4 17
Inferior occipital gyrus
Right 19 32 −78 9 7
Fusiform gyrus
Right 37 36 −56 −7 37
Middle temporal gyrus
Right 21 54 −37 −2 6
Lingual gyrus
Right 18 14 −85 −7 106 0.004004
Medial frontal gyrus
Left 6 −4 4 48 66 0.005116
Cingulate gyrus
Left 24 −4 4 42 15
Cerebellum
Right 29 −63 −13 9 25 −70 −13 9
Brain regions showing significant trends of activation to increasing intensity of emotion (neutral, mild, intense) for fearful and disgusted expressions. Both groups
showed positive trend (i.e. increasing activation with the increasing emotional intensity) for ‘fear’. For ‘disgust’, the 22q11DS group showed positive trend whereas
the controls showed negative trends (i.e. decreasing activation with increasing emotional intensity—shown in italics). Statistical thresholds adjusted so as to get
less than one false positive cluster per map.
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emotion for the fear and disgust experiments are shown
in Tables 4 and 5, respectively. In brief, controls showed
significantly higher activations than people with 22q11DS
in response to fearful emotion in the postcentral gyrus,
the left superomedial frontal gyrus, and the bilateral cere-
bellum across emotional intensities. For disgusted facial
Table 3 The main effect of group and group × intensity interaction
Fear Disgust
Brain region BA X Y Z Size p value X Y Z Size p value
Controls > 22q11DS
Fusiform gyrus
Left 19 −36 −74 −13 27 −40 −70 −18 49
Right 19 29 −81 −13 119 0.003945
Inferior occipital gyrus
Left 19 −36 −78 −7 5
Insula
Left 13 −29 −30 26 10
Superior frontal gyrus
Right 6 4 11 48 164 0.003543
Postcentral gyrus
Left 3 −32 −30 48 37 −29 −30 48 180 0.001517
Precentral gyrus
Left 4 −36 −19 48 136 0.000273 −36 −19 53 21
Transverse temporal gyrus
Left 41 −47 −22 9 5
Cingulate gyrus
Right 32 0 11 37 33
Cerebellum
Left −36 −79 −18 186 0.000273 −40 −44 −24 173 0.000305
Right 25 −74 −24 40
GROUP × INTENSITY
Fusiform gyrus
Left 19 −32 −74 −18 22
Precentral gyrus
Left 4 −32 −22 53 50 0.005263 −29 −22 53 92 0.00246
Medial frontal gyrus
Right 6 0 −11 53 7
Superior frontal gyrus
Right 6 0 4 48 23
Cingulate gyrus
Right 24 0 4 42 63 0.006812
Postcentral gyrus
Left 3 −32 −33 48 21 −32 −22 42 27
Inferior parietal lobule
Left 40 −47 −30 31 5
Cerebellum
Left −40 −70 −24 99 0.002271
Brain regions showing main effects of group and group × intensity level interactions for each emotion experiment. Talairach coordinates in italic print indicate the
most activated voxel within a cluster. Other Talairach coordinates represent other active areas in clusters (derived from decomposition of each cluster into
contiguous slices, 5.72-mm diameter in the z dimension). Statistical thresholds adjusted so as to get less than one false positive cluster per map.
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emotion, controls activated significantly more than the
22q11DS group in the left fusiform gyrus, left postcentral
gyrus, and the bilateral cerebellum. We found that there
were no brain regions where people with 22q11DS acti-
vated more than controls in response to fearful, disgusted,
or neutral facial expressions.
Correlation with behavioural measures
Eleven children with 22q11DS and nine siblings pro-
vided the parent’s version of the SDQ. The siblings
scored well under the cut-off scores for all of the sub-
scales, while children with 22q11DS scored in the bor-
derline—abnormal range for the ‘Emotional Symptoms’
and ‘Peer Problems’ scores which are related to social
behaviour (see Table 1). These two subscales were the
only ones that yielded significant group difference. We
used the ‘Total Difficulties Score’ for exploratory correl-
ation analysis which is generated by summing the subscale
scores including these two because it is a well-established
measure for screening for behavioural, emotional, and
social difficulties among children both at home and school
[84,93,101,102]. In children with 22q11DS, we found a sig-
nificant correlation between decreasing brain activations
as the SDQ Total Difficulties Score increased, to fearful
expressions in the left precentral gyrus (BA 4, r = 0.453),
and to disgusted expressions in the left fusiform gyrus
(BA 19, r = 0.447), right lingual gyrus (BA 18) (Figure 3),
and bilateral cerebellum (r = 0.613).
Discussion
We carried out a cross-sectional event-related fMRI study
in children and adolescents with 22q11DS and healthy
controls. We examined neural responses to increasing in-
tensities of two primary emotions—fear and disgust. Our
main findings were that a) fusiform-extrastriate cortices
and other components of ‘face responsive’ networks are
engaged by fearful, disgusted, and neutral expressions
both in young individuals with 22q11DS and in healthy
controls; b) children with 22q11DS, like healthy controls,
show increased activity in visual cortices and other brain
Figure 1 Main effect of group analyses demonstrating regions where controls activate more than people with 22q11DS in response
to disgusted expression. Controls showed significantly greater activation in extrastriate and fusiform cortices than children with 22q11DS.
Twenty-five 5.5-mm slices extend from z=−51.15 to z= 69.85. See Table 3 for a full description of the functional anatomy and peak Talairach coordinates.
Figure 2 Main effect of group analyses demonstrating regions where controls activate more than people with 22q11DS in response to
fearful expression. Controls showed significantly greater activation in extrastriate and fusiform cortices than children with 22q11DS. Twenty-five
5.5-mm slices extend from z = −51.15 to z = 69.85. See Table 3 for a full description of the functional anatomy and peak Talairach coordinates.
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regions with increasing intensity of fearful expressions;
c) but, compared to controls, children with 22q11DS dis-
play a different pattern of modulation (i.e. increased acti-
vation) of right extrastriate cortical activity with increasing
intensity of disgusted expressions.; and d) despite these
between-group differences in the modulation of brain ac-
tivity by emotion type and intensity, there were no brain
regions where young people with 22q11DS showed greater
activation to facial expressions of any type or intensity
compared to typically developing controls. This is in line
with previous findings of reduced FG response to faces in
young people with 22q11DS [78] and is, in part, consistent
with prior findings of frontal hyporesponsiveness to mixed
facial expressions of emotion in adults with 22q11DS [75].
However, while the latter study reported higher activation
of posterior regions in adults with 22q11DS compared to
controls [75], as noted, we found no brain regions where
the neural activations were higher in the 22q11DS group.
In addition, between-group differences in regional brain
activation to facial expressions appear to be directly
related to difficulties in social behaviour. For example, we
found a negative correlation between brain activity and
SDQ total difficulties score (a measure of difficulties in be-
haviour, emotions, and relationships) in the left precentral
gyrus (BA 4) (for fear) and in the left FG (BA 19), right lin-
gual gyrus (BA 18), and bilateral cerebellum (for disgust).
Consequently, reduced responsiveness of these ‘face re-
sponsive’ regions to facial expressions of fear and disgust
may contribute to the difficulties in social behaviour in
people with 22q11DS. However, given the small sample
size in the current study, further studies with larger sam-
ples will be required to validate this finding.
Similar findings of reduced activations of fusiform-
extrastriate cortices to emotional and neutral facial ex-
pressions have been reported in an event-related fMRI
study of people with ASD compared to healthy controls,
using a similar incidental facial emotion processing task
[103]. It has been suggested that fusiform-extrastriate
hypoactivation in people with ASD may result from a
failure of feedback modulation from limbic structures
Table 4 Post hoc analyses on group × intensity interaction for fear
Intense Mild Neutral
Brain region BA X Y Z Size X Y Z Size X Y Z Size
Control > 22q11DS
Fusiform gyrus
Left 19 −29 −81 −13 24 −36 −70 −13 26
Right 19 33 −78 −13 64
Thalamus
Left −7 −15 15 7
Paracentral lobule
Left 31 0 −11 48 13
Precentral gyrus
Left 4 −32 −22 53 23 −36 −22 53 22
Postcentral gyrus
Left 3 −33 −22 48 135 −33 −22 48 174 −40 −26 48 80
Medial frontal gyrus
Left 32 7 11 42 23 0 11 42 128
Superior frontal gyrus
Left 6 7 11 48 99
Right 6 4 11 48 31
Cingulate gyrus
Left 24 −7 7 26 7 0 15 37 95
Right 32 11 11 37 22 11 11 37 27 0 −4 26 16
Cerebellum
Left −33 −70 −24 135 −33 −67 −29 120 −36 −70 −18 163
Right 36 −70 −24 84
Post hoc between-group two-way ANOVA comparisons of neural responses to intense, mild, and neutral expressions, respectively, for fearful emotion experiment.
Talairach coordinates in italic print indicate the most activated voxel within a 3D cluster. Other Talairach coordinates represent other active areas in clusters
(derived from decomposition of each cluster into contiguous slices, 5.72-mm diameter in the z dimension). Statistical thresholds adjusted so as to get less than
one false positive cluster per map.
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[63]. Similarly, fusiform-extrastriate hypoactivation in
young people with 22q11DS may also relate to amygdala
and other limbic abnormalities. For example, there is
evidence of a lack of amygdala modulation by fearful
expressions in young people with 22q11DS [78], while
anomalies in limbic structures, along with other regions,
have been reported from studies in 22q11DS [87,104,105].
The non-uniform pattern of between-group differences
across emotion types and intensities in our study suggests
that reduced feedback modulation from the amygdala may
not be the sole explanation for our findings in 22q11DS.
An alternative possibility is that limbic modulation of vis-
ual cortices involves the amygdala acting in concert with
other limbic structures depending on the type and inten-
sity of emotion. This hypothesis would be consistent both
with the view that the amygdala is involved in conferring
salience on a wide range of social and non-social stimuli
[106] and with studies that reported differential activation
of limbic structures in response to distinct facial emotion
types—such as the amygdala for fear [107] and insula for
disgust [108]. Hence, the between-group differences we
found between people with 22q11DS and controls in
Table 5 Post hoc analyses on group × intensity interaction for disgust
Intense Mild Neutral
Brain region BA X Y Z Size X Y Z Size X Y Z Size
Control > 22q11DS
Fusiform gyrus
Left 19 −40 −70 −13 24 −36 −67 −13 23
Right 32 −78 −13 19
Inferior parietal lobule
Left 40 −40 −37 37 32
Insula
Left 13 −29 −30 26 8 −43 −30 20 8
Precentral gyrus
Left 4 −36 −19 53 6 −29 −26 53 18 −36 −15 53 14
Postcentral gyrus
Left 3 −29 −30 48 72 −29 −30 48 162 −33 −22 42 125
Middle occipital gyrus
Left 18 −22 −85 −7 5
Medial frontal gyrus
Left 32 0 7 42 72
Cingulate gyrus
Right 24 7 7 37 19
Cerebellum
Left 36 -48 -24 78 -40 -70 -18 85 -36 -67 -18 173
Right -43 -59 -29 148 25 -81 -24 78 33 -78 -18 137
Post hoc between-group two-way ANOVA comparisons of neural responses to intense, mild, and neutral expressions, respectively, for disgusted emotion experiment.
Talairach coordinates in italic print indicate the most activated voxel within a cluster. Other Talairach coordinates represent other active areas in clusters (derived from
decomposition of each cluster into contiguous slices, 5.72-mm diameter in the z dimension). Statistical thresholds adjusted so as to get less than one false positive
cluster per map.
Figure 3 Correlation between SDQ total difficulties score and
brain activity (SSQ) in brain regions that show reduced
activation to disgusted expressions compared to healthy
controls. A significant negative correlation between SDQ total
difficulties score and brain activity (SSQ) was demonstrated within
the right cerebellum/lingual gyrus (BA 18). Statistical thresholds
adjusted so as to get less than one false positive cluster per map.
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visual cortical activation may reflect differences in modu-
latory input from limbic and other brain regions that vary
with emotion type and intensity.
Compared to controls, the 22q11DS group also showed
reduced activation in the anterior cingulate gyrus (BA 32/
24). The dorsal region of the anterior cingulate cortex (BA
24/32) has been implicated in executive function, such as
selective attention and planning, as well as in the regula-
tion of affective states [46]. Hence, hypoactivation of the
anterior cingulate gyrus in response to a range of expres-
sion types and intensities may relate to difficulties in regu-
lating affective responses to emotional stimuli and in
integrating affective responses to expressions with the ex-
ecutive control of behaviour.
Reduced brain activation in the 22q11DS group was also
found in the superomedial prefrontal cortex (BA 6). Acti-
vation of this area in response to facial emotion stimuli has
been reported in neuroimaging studies employing similar
facial emotion processing tasks [60,103]. In addition, BA 6
is also active during the production of empathetic facial
expressions [109-111]. Relative hypoactivation of super-
omedial prefrontal regions in 22q11DS may therefore
be related both to the failure to recognize and/or
affectively respond to the facial displays of others and
to the lack of facial expression reported in people with
22q11DS [17,30].
Activations in the cerebellum during facial emotion
and other affective processing tasks have been reported
by prior human studies [57,64,65,67,103,112-114]. While
no consistent differential brain activations in facial emo-
tion processing tasks have been found [57], it has been
suggested that the cerebellum may contribute both to
empathic processing [115,116] and to the generation of
affective states [104,117]. Thus, the lower cerebellar acti-
vation observed in children with 22q11DS as compared
to the healthy controls may result in diminished affective
responsiveness to facial displays of expression. Cerebellar
hypoactivation to facial expressions may also be associ-
ated with problems in social behaviour. For example, we
found a significant negative correlation between adaptive
social behaviour (as measured by the SDQ total difficulty
scores which measure difficulties in behaviour, emotions,
and peer relationships) and the left cerebellar activation
to disgust in people with 22q11DS [103].
One possible explanation for differences in modulation
of social brain regions by different types and intensity of
facial expression may be variation in dopamine metabol-
ism—for example, associated with variation in catechol-
O-methyl transferase (COMT), a methylation enzyme
that metabolizes catecholamines (including dopamine)
[118]. In other words, dopamine levels in social brain re-
gions could be abnormal in people with 22q11DS who
have haploinsufficiency in COMT [119-122]. We will ad-
dress this issue in future larger studies.
Alternatively, differences in function of social brain re-
gions may be explained by differences in brain anatomy.
We have previously reported a relationship between dif-
ferences in regional brain volume and social behaviour
in young people with 22q11DS [87]. Thus, larger studies
are required to investigate the relationship between dif-
ferences in anatomy and function (if any).
There are several limitations in our study. For example,
the sample size was relatively small, and the controls
scored significantly higher on tests of intellectual function-
ing compared to people with 22q11DS (FSIQ: 114 vs. 66).
Hence, it could be suggested that our results may be
explained by differences in intellectual ability, and it might
therefore have been better to have included an IQ-
matched non-deleted control group who were also
matched on social and environmental factors. However, we
compared people with 22q11DS to healthy controls (in-
cluding siblings of the 22q11DS participants, when avail-
able) because we wanted to find out how brain activation
in people with 22q11DS differs from those with optimal
brain development. Also, both groups showed activations
in brain regions reported by others to be specifically impli-
cated in facial emotion processing [59,60], and the pattern
of the results remained unchanged even when we analysed
the group differences using FSIQ as a covariate. Further-
more, unrelated controls with intellectual disabilities would
most likely have comprised a heterogeneous population
with a large variety of genetic and environmental/social dif-
ferences. Hence, where possible, we used sibling controls
to account, as best we could, for environmental and social
differences. Thus, the significantly higher activations in the
healthy control group probably cannot be solely attributed
to environmental and/or socio-economic factors. Another
point regarding the use of siblings as controls is that they
may not represent typically developing healthy children.
For example, imaging studies on individuals with autism
have shown that non-autistic siblings of individuals with
autism showed patterns of brain activation that are similar
to those with autism [123] or different from those with aut-
ism and non-sibling controls [124]. Future research could
therefore include sibling and non-sibling controls to ad-
dress the issue of whether there are any differences in brain
activation between sibling and non-sibling controls in the
case of 22q11DS.
We did not acquire behavioural data about accuracy of
facial emotion recognition because we employed inci-
dental (gender discrimination) rather than explicit (emo-
tion recognition) task. An incidental emotion processing
task was chosen because emotion appraisal in routine
social interaction often occurs automatically (without
conscious deliberation) [125]. Therefore, we believe our
paradigm to be more appropriate for investigating
between-group differences in brain systems that are rou-
tinely engaged in social interaction.
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We found widespread limbic and subcortical activa-
tions in our face versus fixation cross contrasts for both
disgusted and fearful emotion across different levels of
intensity (see Additional file 1) and between-group dif-
ferences in activation of the insula to disgusted expres-
sions (see the “Results” section). In contrast, we failed to
find activation of the amygdala in any of our contrasts.
However, not all previous studies of facial fear percep-
tion in healthy participants have demonstrated amygdala
activation [126]. Similarly, the previous study on facial
emotion processing in adults with 22q11DS reported
higher insula activation in the control group, but they
found no between-group difference in amygdala activa-
tions [75]. These results may not necessarily reflect ab-
sence of amygdala activation but, rather, limitations of
MRI acquisition and the relatively small sample size in
these studies. However, despite the relatively small sam-
ple size (n = 14), our results demonstrate that we had
sufficient statistical power to detect differences in activa-
tion. Also, the areas we report are likely to remain differ-
entially active even if additional active areas are revealed
by increased sample size and optimized MRI acquisition
parameters. Moreover, the results we report are likely to
represent true activations because of the use of a conser-
vative analysis and thresholding method to reduce the
risk of Type 1 errors (see the “Methods” section).
Conclusions
Both children and adolescents with 22q11DS and healthy
controls demonstrated activation in ‘face responsive’ re-
gions, including fusiform-extrastriate cortices, anterior
cingulate cortex (BA 24), and superomedial prefrontal cor-
tex (BA 6) in response to facial expressions of emotion
(fear and disgust). However, the patterns of these activa-
tions vary depending on emotion type and intensity and
differ between groups. Furthermore, compared to healthy
controls, children with 22q11DS consistently showed sig-
nificantly lower brain activations for both emotion types,
across intensities, in these regions. Activity in some of
these regions (e.g. left precentral gyrus (BA 4) to fear, and
left FG (BA 19) and right lingual gyrus (BA 18) to disgust)
also negatively correlated with the extent of social difficul-
ties. Hypoactivation in these regions may therefore partly
explain the social impairments of children with 22q11DS.
However, further studies are required to determine the re-
lationship between these findings and the social impair-
ments of people with 22q11DS and how these
abnormalities arise and change with age.
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